This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dharminder Chauhan and Patent Innovation
Introduction
Dharminder Chauhan is an inventor associated with Dana-Farber Cancer Institute Inc. His listed patent concerns a potential treatment approach for multiple myeloma.
Latest Patents
Chauhan is credited with 1 patent: “Novel USP7 Inhibitors for Treating Multiple Myeloma.” The invention focuses on USP7 inhibitors and their potential use in treating this cancer.
Career Highlights
The available information identifies Chauhan’s work in connection with Dana-Farber Cancer Institute Inc. and research directed toward a therapeutic application for multiple myeloma.
Collaborations
The patent listing connects Chauhan’s invention with Dana-Farber Cancer Institute Inc. No additional collaborators are specified in the provided information.
Conclusion
Dharminder Chauhan’s listed patent reflects research into USP7 inhibitors as a potential approach to treating multiple myeloma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile